GLP-1s
Article
Study finds GLP-1s show potential for managing comorbid depression and anxiety
July 17, 2025
GLP-1s may offer benefits beyond managing blood sugar.
Article
Express Scripts expands Patient Assurance Program to drive affordability and access to GLP-1s
July 10, 2025
Express Scripts will add GLP-1s for weight loss to the Patient Assurance Program (PAP), made possible by collaboration with Lilly and Novo Nordisk.
Newsroom
Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month
May 21, 2025
• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible
• New offering helps employers meet growing ...
Article
New Evernorth EnReachRx model expands its suite of GLP-1 solutions, works to improve patient outcomes and drive value
Read More
Article
Podcast: Understanding GLP-1 market challenges and actionable strategies for managing impact
Listen to the latest episode of the Health Unscripted Podcast for a deep dive into the challenges and opportunities within the GLP-1 landscape.
Read More
Report
Pharmacy in Focus: Navigating GLP-1 cost, demand and sustainability
With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.
Read More